SCHEMBL29923356

SCHEMBL29923356

COc1cc2c(Br)cc(C)cc2nc1C

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PRNP P04156 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NQO2 P16083 4/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
SLC2A1 P11166 2/20 0.36
ACHE P22303 1/20 0.35
FBP1 P09467 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PDE10A Q9Y233 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4D Q08499 1/20 0.35
EGFR P00533 1/20 0.35
PSMB5 P28074 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24916334 1.00 MAPT (0.46) MAPTALDH1A1PRNPNPSR1RXFP1
SCHEMBL27901375 0.82 PSMB5 (0.50) MAPTALDH1A1PRNPNPSR1RXFP1
SCHEMBL31353452 0.80 PRKDC (0.39) MAPTALDH1A1NQO2PDE3BPDE3A
SCHEMBL31353408 0.80 KDM4E (0.40) ALDH1A1NPSR1RXFP1NQO2PDE3B
SCHEMBL24915779 0.78 MAPT (0.45) MAPTALDH1A1PRNPNPSR1RXFP1
SCHEMBL29923988 0.78 MAPT (0.45) MAPTALDH1A1PRNPNPSR1RXFP1
SCHEMBL24915598 0.77 PDE3B (0.40) MAPTALDH1A1PRNPNPSR1RXFP1
SCHEMBL31353367 0.75 EPAS1 (0.34) PSMB5
SCHEMBL31353603 0.75 HPGD (0.43) MAPTALDH1A1PRNPNPSR1NQO2
SCHEMBL23208763 0.72 RXFP1 (0.46) MAPTALDH1A1PRNPNPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121586713-A Quinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases 百济神州(苏州)生物科技有限公司 2026-02-27 CN disclosed
WO-2025021217-A1 QUINOLINE DERIVATIVES AND PHARMARCEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASE BEIGENE SWITZERLAND GMBH (CH) 2025-01-30 WO disclosed
EP-4055013-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2022-09-14 EP disclosed